Back

Comparison of the safety and efficacy of antithrombotic regimens following TAVR in patients without having an indication for chronic oral anticoagulation

27 August 2022 (16:20 - 16:30)
Organised by:
Congress Presentation Part of: Transcatheter aortic valve implantation: trends, outcomes, and procedural considerations Aortic Valve Intervention ESC Professional Premium Access ESC Congress 2022

About the speaker

Photo
Doctor Paul Guedeney

Pitie Salpetriere APHP University Hospital, Paris (France)

5 More presentations in this session

Presentation thumbnail
Trends in outcomes, complications and readmission rates in patients undergoing transcatheter aortic valve implantation: a nationwide analysis from 2012 to 2019
Doctor A. Goel (Valhalla, US)
Abstract Slides Video
Presentation thumbnail
Hospital procedural volume and clinical outcomes for transcatheter aortic valve replacement - US nationwide readmission database, 2016-2019.
Doctor O. Al-Taweel (Las Vegas, US)
Abstract Slides Video
Presentation thumbnail
Prevalence and prognostic impact of cardiac amyloidosis in patients with severe aortic stenosis undergoing transcatheter aortic valve implantation. AMY-TAVI study.
Doctor D. Lopez Otero (Santiago de Compostela, ES)
Abstract Slides Video
Presentation thumbnail
Impact of periprocedural pulmonary hypertension on outcomes after TAVR: novel risk stratification from the OCEAN-TAVI Registry
Doctor J. Miyamoto (Kanagawa, JP)
Abstract Slides Video
Presentation thumbnail
Bioprosthetic valve fracture during valve-in-valve transcatheter aortic valve replacement: multicenter propensity matched analysis
Doctor G. Bonnet (Bordeaux, FR)
Abstract Slides Video

Access the full session

Session thumbnail
Transcatheter aortic valve implantation: trends, outcomes, and procedural considerations

The Event

Event poster

ESC Congress 2022

27 August 2022 16:20 CET
You may be interested in
thumbnail
Congress Presentation
Atrial fibrillation and TAVI or bioprosthetic heart valves: who and how to anticoagulate
thumbnail
Congress Session
Outcomes and strategies in left atrial appendage closure
thumbnail
Congress Session
Next frontier in stroke prevention with left atrial appendage closure: the CHAMPION-AF Trial

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources